<DOC>
	<DOCNO>NCT02524795</DOCNO>
	<brief_summary>Omega-3 fatty acid consider anti-inflammatory lipid base data epidemiological study Greenland Eskimos whose diet rich fish , source polyunsaturated fatty acid . Fatty acids omega-3 family [ mainly α-linolenic acid , eicosapentaenoic ( EPA ) docosahexaenoic ( DHA ) ] , well omega-6 family [ represent mainly linoleic acid arachidonic acid ( AA ) ] essential synthesis eicosanoids , prostaglandin , leukotrienes , thromboxanes oxidative factor , major mediator regulator inflammation . Systemic lupus erythematosus ( SLE ) inflammatory autoimmune disease characterize loss balance cellular immunoregulation increase level circulate inflammatory mediators.Thus , omega-3 supplementation could represent additional therapy individual SLE . The aim study investigate effect omega-3 fatty acid circulate level inflammatory biochemical marker woman SLE .</brief_summary>
	<brief_title>Omega 3 Fatty Acids Systemic Lupus Erythematosus</brief_title>
	<detailed_description>This pilot clinical trial omega-3-polyunsaturated fatty acid carry SLE patient follow Rheumatology Unit Hospital da Clínicas , Universidade Federal de Minas Gerais , UFMG . Female patient meet revised American College Rheumatology ( ACR ) classiﬁcation criterion SLE ( 1982/1997 ) 15 , age 18 year old 60 year old , take stable dos medication SLE treatment last three month include . Exclusion criterion follow : pregnancy , disease duration le one year , allergy ﬁsh , ﬁsh oil omega-3 product , omega-3 use within previous six month diagnosis diabetes mellitus , liver disease , chronic renal failure , type infection enrollment and/or throughout study . A 12 week pilot clinical trial omega-3 fatty acid supplementation conduct . Participants see baseline ( T0 ) week 12 ( T1 ) clinical , laboratory nutritional assessment . Participants also contact telephone week 6 check compliance adverse event . The patient randomize one two group 1:1 ratio . Patients study group receive , throughout 12 week , two tablet per day omega-3 fatty acid ( 540mg EPA DHA 100mg ; Hiomega-3 supplement Naturalis® company - registered National Health Department number 4.1480.0006.001-4 ) . Patients control group receive nutrient kind placebo . All participant instruct take omega-3 rich food study period . The researcher ( FMMS ) clinical assessment inflammatory biochemical data assessment blind randomization intervention . Variables measure visit include : disease activity index , use Systemic Lupus Disease Activity Index ( SLEDAI-2k ) 16 ; damage index ( Systemic Lupus International Collaboration Clinics/American College Rheumatology damage index - SLICC/ACR ) 17 ; fast lipid glucose proﬁle ; standard laboratory test assess SLE ( red white blood count , platelet count , creatinine , urinalysis , urine protein/creatinine ratio , anti-dsDNA , anticardiolipin , C3 C4 level ) ; cytokine ( IL-6 , IL-10 ) , adipokines ( leptin , adiponectin ) C-reactive protein ( CRP ) , nutritional assessment , use medication .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>1Diagnosis lupus accord American College Rheumatology ( ACR ) classiﬁcation criterion SLE ( 1982/1997 ) Taking stable dos medication SLE treatment last three month . pregnancy , disease duration le one year , allergy ﬁsh , ﬁsh oil omega3 product , omega3 use within previous six month diagnosis diabetes mellitus , liver disease , chronic renal failure , type infection enrollment and/or throughout study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Omega 3 , Cytokines , Adipokines , Systemic lupus erythematosus</keyword>
</DOC>